Moreover, it was evaluated that OS of patients with DTCs in BM and VEGF-positive tumor was significantly shorter than that of patients without DTCs in BM and VEGF-positive tumor (P = 0.0486) (Figure 3). The gene discussed is VEGFA; the disease is neoplasm.